Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Universidade Estadual Paulista (Unesp) | - |
Autor(es): dc.contributor | University of Southern Denmark | - |
Autor(es): dc.creator | Calanca, Naiade [UNESP] | - |
Autor(es): dc.creator | Abildgaard, Cecilie | - |
Autor(es): dc.creator | Rainho, Cláudia Aparecida [UNESP] | - |
Autor(es): dc.creator | Rogatto, Silvia Regina | - |
Data de aceite: dc.date.accessioned | 2022-02-22T00:52:07Z | - |
Data de disponibilização: dc.date.available | 2022-02-22T00:52:07Z | - |
Data de envio: dc.date.issued | 2021-06-25 | - |
Data de envio: dc.date.issued | 2021-06-25 | - |
Data de envio: dc.date.issued | 2020-09-01 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.3390/cancers12092701 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/207997 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/207997 | - |
Descrição: dc.description | Comprehensive large-scale sequencing and bioinformatics analyses have uncovered a myriad of cancer-associated long noncoding RNAs (lncRNAs). Aberrant expression of lncRNAs is associated with epigenetic reprogramming during tumor development and progression, mainly due to their ability to interact with DNA, RNA, or proteins to regulate gene expression. LncRNAs participate in the control of gene expression patterns during development and cell differentiation and can be cell and cancer type specific. In this review, we described the potential of lncRNAs for clinical applications in ovarian cancer (OC). OC is a complex and heterogeneous disease characterized by relapse, chemoresistance, and high mortality rates. Despite advances in diagnosis and treatment, no significant improvements in long-term survival were observed in OC patients. A set of lncRNAs was associated with survival and response to therapy in this malignancy. We manually curated databases and used bioinformatics tools to identify lncRNAs implicated in the epigenetic regulation, along with examples of direct interactions between the lncRNAs and proteins of the epigenetic machinery in OC. The resources and mechanisms presented herein can improve the understanding of OC biology and provide the basis for further investigations regarding the selection of novel biomarkers and therapeutic targets. | - |
Descrição: dc.description | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | - |
Descrição: dc.description | Department of Chemical and Biological Sciences Institute of Biosciences São Paulo State University (UNESP) | - |
Descrição: dc.description | Department of Oncology University Hospital of Southern Denmark-Vejle Institute of Regional Health Research University of Southern Denmark | - |
Descrição: dc.description | Department of Clinical Genetics University Hospital of Southern Denmark-Vejle Institute of Regional Health Research University of Southern Denmark | - |
Descrição: dc.description | Department of Chemical and Biological Sciences Institute of Biosciences São Paulo State University (UNESP) | - |
Formato: dc.format | 1-21 | - |
Idioma: dc.language | en | - |
Relação: dc.relation | Cancers | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | Epigenetic regulators | - |
Palavras-chave: dc.subject | LncRNA databases | - |
Palavras-chave: dc.subject | LncRNAs | - |
Palavras-chave: dc.subject | Ovarian cancer | - |
Palavras-chave: dc.subject | Transcriptional regulation | - |
Título: dc.title | The interplay between long noncoding rnas and proteins of the epigenetic machinery in ovarian cancer | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: